Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
This study has been approved by the Research Ethics Committee of the Professor Edgard Santos University Hospital Complex, Salvador BA, Brazil, under protocol 2.635.954. The study is carried out according to guidelines and regulatory standards for research involving humans, as set out in Brazilian legislation. Trial registration - ClinicalTrials.gov : NCT03749070. November 21, 2018
Source: Trials - Category: Research Source Type: clinical trials
More News: Alcoholism | Brazil Health | Clinical Trials | Complementary Medicine | Computers | CT Scan | Fatty Liver Disease (FLD) | Herbs | Hospitals | Liver | Liver Disease | Medical Ethics | Non-alcoholic Fatty Liver Diseases (NAFLD) | PET Scan | Research | Study | Urology & Nephrology | Vitamin E | Vitamins